CVRx said Staten Island University Hospital has completed its first Barostim implant, expanding access to the company’s device-based cardiovascular therapy. The

CVRx said Staten Island University Hospital has completed its first Barostim implant, expanding access to the company’s device-based cardiovascular therapy. The rollout points to broader hospital adoption as CVRx advances Barostim in heart failure care.